Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 14 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-1.83 Insider Own9.51% Shs Outstand8.60M Perf Week-15.73%
Market Cap4.06M Forward P/E4.72 EPS next Y0.10 Insider Trans0.00% Shs Float7.78M Perf Month0.73%
Income-7.13M PEG- EPS next Q-0.06 Inst Own36.79% Short Float0.23% Perf Quarter-23.89%
Sales6.11M P/S0.66 EPS this Y96.57% Inst Trans-4.67% Short Ratio0.58 Perf Half Y-62.55%
Book/sh0.41 P/B1.16 EPS next Y225.00% ROA-63.39% Short Interest0.02M Perf Year-71.05%
Cash/sh1.13 P/C0.42 EPS next 5Y40.00% ROE-253.55% 52W Range0.40 - 1.89 Perf YTD-55.07%
Dividend Est.- P/FCF- EPS past 5Y15.68% ROI-203.85% 52W High-75.03% Beta0.37
Dividend TTM- Quick Ratio1.32 Sales past 5Y1418.11% Gross Margin96.01% 52W Low17.97% ATR (14)0.06
Dividend Ex-Date- Current Ratio1.39 EPS Y/Y TTM27.23% Oper. Margin-110.99% RSI (14)43.92 Volatility11.11% 11.46%
Employees4 Debt/Eq1.43 Sales Y/Y TTM110.49% Profit Margin-116.76% Recom1.00 Target Price7.00
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q74.07% Payout- Rel Volume0.86 Prev Close0.53
Sales Surprise-18.83% EPS Surprise19.05% Sales Q/Q114.15% EarningsMay 14 AMC Avg Volume30.60K Price0.47
SMA20-4.26% SMA50-3.76% SMA200-45.62% Trades Volume26,288 Change-10.13%
Date Action Analyst Rating Change Price Target Change
Jun-22-20Upgrade H.C. Wainwright Neutral → Buy $10
Mar-05-19Downgrade H.C. Wainwright Buy → Neutral
Mar-08-18Reiterated B. Riley FBR, Inc. Buy $10 → $5
Oct-19-17Resumed FBR & Co. Buy $10
Mar-16-17Reiterated Rodman & Renshaw Buy $6 → $9
Jan-30-17Upgrade Laidlaw Neutral → Buy $8
Jan-05-17Upgrade Rodman & Renshaw Neutral → Buy $2.50 → $6
Dec-23-16Reiterated Rodman & Renshaw Neutral $2 → $2.50
Jul-19-16Reiterated FBR Capital Outperform $17 → $9
Jul-19-16Downgrade Noble Financial Buy → Hold
May-16-24 04:02PM
May-14-24 10:53PM
Apr-17-24 08:30AM
Mar-21-24 04:15PM
01:58PM Loading…
Mar-15-24 01:58PM
Mar-14-24 04:05PM
Mar-07-24 04:10PM
Feb-14-24 07:30AM
Feb-09-24 07:30AM
Nov-30-23 12:16PM
Nov-27-23 08:30AM
Nov-14-23 08:30AM
Nov-09-23 08:30AM
08:30AM Loading…
Oct-31-23 08:30AM
Oct-23-23 06:30AM
Oct-18-23 08:30AM
Sep-14-23 08:30AM
Aug-10-23 08:30AM
Aug-07-23 08:30AM
Jul-25-23 08:30AM
Jun-14-23 08:30AM
May-15-23 04:05PM
May-09-23 07:00AM
May-04-23 08:30AM
May-01-23 08:30AM
Apr-20-23 08:30AM
Apr-06-23 08:30AM
Mar-24-23 07:36AM
08:30AM Loading…
Mar-23-23 08:30AM
Mar-21-23 04:05PM
Mar-15-23 08:30AM
Feb-21-23 07:00AM
Jan-30-23 07:00AM
Jan-18-23 08:30AM
Dec-07-22 08:30AM
Nov-30-22 08:30AM
Nov-12-22 08:03AM
Nov-09-22 04:30PM
Nov-02-22 08:30AM
Oct-20-22 08:44AM
Sep-20-22 08:30AM
Sep-14-22 08:30AM
Sep-06-22 08:30AM
Aug-16-22 08:30AM
Aug-10-22 04:30PM
Aug-03-22 08:30AM
Aug-01-22 08:30AM
Jul-06-22 08:30AM
Jun-15-22 08:30AM
Jun-08-22 08:30AM
May-23-22 07:00AM
May-18-22 08:30AM
May-17-22 08:30AM
May-10-22 04:05PM
May-03-22 08:30AM
Apr-26-22 11:36AM
Apr-19-22 08:30AM
Mar-10-22 08:30AM
Mar-08-22 04:05PM
Mar-01-22 08:30AM
Feb-24-22 08:30AM
Feb-17-22 08:30AM
Feb-02-22 08:30AM
Jan-04-22 08:30AM
Nov-10-21 04:05PM
Nov-03-21 08:30AM
Oct-20-21 08:30AM
Sep-29-21 08:30AM
Sep-10-21 07:53AM
Sep-01-21 08:30AM
Aug-16-21 07:20AM
Aug-12-21 04:05PM
Aug-05-21 08:30AM
Aug-02-21 08:30AM
Jul-14-21 08:30AM
Jun-29-21 08:30AM
Jun-15-21 08:30AM
Jun-08-21 08:30AM
Jun-02-21 08:30AM
May-27-21 08:30AM
May-14-21 08:30AM
May-12-21 02:30PM
May-05-21 08:30AM
Apr-06-21 08:30AM
Mar-30-21 08:30AM
Mar-14-21 04:52AM
Mar-11-21 06:05PM
Mar-04-21 04:05PM
Jan-20-21 08:30AM
Jan-13-21 08:03PM
Evoke Pharma, Inc. is a pharmaceutical company, which engages in the development of drugs for the treatment of gastrointestinal disorders and diseases. It also develops Gimoti, with promotility and anti-emetic effects, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus. The company was founded by Matthew J. D'Onofrio, Cam L. Garner, Scott L. Glenn, and David A. Gonyer in January 2007 and is headquartered in Solana Beach, CA.